FDA Inspection
Somerset Therapeutics LimitedSomerset Therapeutics Limited – FDA Inspection, Jul 23, 2019
Record Details
This FDA Inspection record concerns Somerset Therapeutics Limited, with an inspection on July 23, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ad71e53a-bcc5-49ae-9f2a-fde4cfe64916
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1097269
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Somerset Therapeutics Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Somerset Therapeutics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.